Skip to main content
. 2022 Oct 30;197(1):93–101. doi: 10.1007/s10549-022-06770-6

Fig. 3.

Fig. 3

Kaplan–Meier estimates of progression-free survival in subgroups with or without liver and/or lung metastases. mPFS median progression-free survival, CI confidence interval